NCT02909881

Brief Summary

PhytoSpherix (Phx) is an all-natural, edible polysaccharide extracted from sweet corn. This carbohydrate is the major muscle fuel for intense exercise and its stores are quite small such that one can run out of it during a single exercise bout. Therefore, Phx should provide significant exercise fuel if consumed during exercise. As a result its intake could enhance intense exercise performance by providing additional fuel. This experiment Will investigate the effects of 4 different dosages of Phx consumed throughout a prolonged exercise bout on carbohydrate and fat utilization as well as its oxidation rate and perception of effort during prolonged intense exercise in trained cyclists. Muscle and liver carbohydrate stores will be examined using a non-invasive ultrasound technique.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

September 10, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 21, 2016

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
Last Updated

September 22, 2016

Status Verified

September 1, 2016

Enrollment Period

1 year

First QC Date

September 10, 2016

Last Update Submit

September 21, 2016

Conditions

Keywords

polysaccharideoxidationendurance exercise

Outcome Measures

Primary Outcomes (2)

  • Oxidation of PhytoSpherixat

    Breath samples will be taken starting at 0, 15, 30, 45, 60, 75, 90, 135, up to 150 min from the beginning of the exercise session to measure change in oxidation of PhytoSpherix

    0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session

  • Noninvasive ultrasound measure of glycogen in Vastus lateralis, rectus femoris and liver

    Change in muscle and liver glycogen will be measured 10 min before and 10 min after exercise session. When muscle and liver glycogen content is high, the ultrasound image is hypoechoic (dark), and with glycogen depletion and water loss, the image is hyperchoic (brighter).Three ultrasound measurements at each site will be made by a trained technician using a 12 MHz linear transducer and a standard diagnostic high resolution GE LOGIQ-e ultrasound machine (GE Healthcare, Milwaukee, WI). After calculating statistics on the color bar to determine the general brightness settings of the machine, images will be pre-processed and segmented to isolate the muscle area under analysis using a center crop within the muscle section 25 mm from the top muscle sheath. Comparing these results will help better understand the effect of supplementation of Phx at different rates on any changes in glycogen stores of muscle and liver.

    10 min before and 10 min after the 150 min exercise session

Secondary Outcomes (5)

  • blood glucose concentration

    0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session

  • blood lactate concentration

    0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session

  • Respiratory exchange ratio

    At 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session

  • rate of perceived exertion

    At 0, 15, 30, 45, 60, 75, 90, 135, 150 min from the beginning of the exercise session

  • questionnaire to rate possible gastrointestinal (GI) problems

    At 30, 60, 90, 120 and 150 min from the beginning of the exercise session

Study Arms (1)

Endurance trained male cyclists

EXPERIMENTAL

8 male endurance trained male cyclist will consume varying amounts (0, 1, 1.5 and 2 g/min) of PhytoSpherix (sweet-corn derived sugar) during a 150 min . cycling exercise

Dietary Supplement: Use of PhytoSpherix at 0 g/minDietary Supplement: Use of PhytoSpherix at 1 g/minDietary Supplement: Use of PhytoSpherix at 1.5 g/minDietary Supplement: Use of PhytoSpherix at 2 g/minBehavioral: Cycling exercise

Interventions

PhytoSpherix (Sweet-corn derived sugar) will be fed at 0 g/min during a 150 min cycling exercise

Endurance trained male cyclists

PhytoSpherix (Sweet-corn derived sugar) will be fed at 1 g/min during a 150 min cycling exercise

Endurance trained male cyclists

PhytoSpherix (Sweet-corn derived sugar) will be fed at 1.5 g/min during a 150 min cycling exercise

Endurance trained male cyclists

PhytoSpherix (Sweet-corn derived sugar) will be fed at 2 g/min during a 150 min cycling exercise

Endurance trained male cyclists

Male endurance athletes will complete a cycling exercise for 150 min at 50% of their respective maximum wattage

Endurance trained male cyclists

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy male endurance trained athletes with \>2 y cycling experience; about 2 h/day

You may not qualify if:

  • Unhealthy athletes, smokers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Exercise Nutrition Research Laboratory, Western University

London, Ontario, N6A 3K7, Canada

Location

Related Publications (1)

  • Bandegan A, Huang L, Longstaffe FJ, Lemon PW. Dose-Response Oxidation of Ingested Phytoglycogen during Exercise in Endurance-Trained Men. J Nutr. 2021 Oct 1;151(10):2942-2948. doi: 10.1093/jn/nxab219.

MeSH Terms

Conditions

Hypoglycemia

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Peter Lemon, PhD

    Western University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Peter Lemon, PhD

CONTACT

Arash Bandegan, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 10, 2016

First Posted

September 21, 2016

Study Start

September 1, 2016

Primary Completion

September 1, 2017

Study Completion

September 1, 2017

Last Updated

September 22, 2016

Record last verified: 2016-09

Data Sharing

IPD Sharing
Will not share

Locations